From July 20, 2023 to September 30, 2023, the company has repurchased 58,478 shares, representing 0.2% for $21.32 million. With this, the company has completed the repurchase of 58,478 shares, representing 0.2% for $21.32 million under the buyback announced on July 20, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
286.1 USD | -0.39% | -1.16% | -11.40% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.40% | 8.13B | |
-7.38% | 177B | |
-0.46% | 108B | |
-6.98% | 65.55B | |
+2.65% | 50.66B | |
+5.27% | 42.58B | |
+5.73% | 40.74B | |
+19.92% | 31.07B | |
+16.57% | 25.45B | |
-7.00% | 23.85B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Tranche Update on Bio-Rad Laboratories, Inc.'s Equity Buyback Plan announced on July 20, 2023.